Carmat : A major stride in its conquest of the US
>CMS confirms coverage for its artificial heart - The group announced yesterday evening that CMS (Centers for Medicare & Medicaid Services) has approved coverage for its artificial heart as well as routine care items and services supplied to Medicare beneficiaries to be enrolled in the US clinical feasibility study. This is obviously excellent news which is likely to be welcomed by the markets today. In the current context, this rapid response from the CMS illust...Carmat is focused on the research and development of an innovative product in the medical sector, developing an orthotopic and biocompatible artificial heart which is completely implantable, as well as its electrical power supply system and remote diagnosis system. Co. is developing a long-term therapeutic solution for patients who suffer from advanced bi-ventricular heart failure and who are not eligible for cardiac transplantation and who have exhausted all drug possibilties. Co. is still in the phase of research and development and thus do not generate any revenues.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.